Alaunos (TCRT) Director Jerman Michael Allen Receives Award of 8,138 Shares

What Happened
Jerman Michael Allen, a director of Alaunos Therapeutics, received an award of 8,138 shares of common stock on July 23, 2026. The filing shows an acquisition price of $1.92 per share, putting the grant value at about $15,625. This was an award issued in lieu of board fees (compensation), not an open-market purchase.

Key Details

• Transaction date: 2026-07-23; transaction type: Award/Grant (code A).
• Price recorded: $1.92 per share; total value ≈ $15,625.
• Shares owned after the transaction: Not disclosed in this Form 4.
• Footnote: F1 — shares were issued in lieu of board fees (compensation).
• Filing timeliness: Reported on 2026-07-27 (filed within the standard 2-business-day window).

Context
Awards issued in lieu of board fees are a common form of director compensation and reflect payment rather than a market purchase or sale. Such compensation is routine and should not be interpreted on its own as a signal of the insider’s market sentiment.